Cancer Therapy Vol 2, 263-270, 2004

Calcium signalling and tumorigenesis

Review Article

Juan A. Rosado*, Pedro C. Redondo, José A. Pariente, Ginés M. Salido

Department of Physiology, University of Extremadura, C΅ceres, Spain

__________________________________________________________________________________

*Correspondence: Dr. Juan A. Rosado, Faculty of Veterinary Medicine, Department of Physiology, University of Extremadura. Av. Universidad s/n, 10071 C΅ceres. Spain; Phone: +34 927257154; Fax: +34 927257154; e-mail: jarosado@unex.es

Key words: calcium, tumorigenesis

Abbreviations: calcium-sensing receptors, (CaR); cytosolic calcium concentration, ([Ca²⁺]_c); calcium concentration in the stores, ([Ca²⁺]_s); mitochondrial calcium concentration, ([Ca²⁺]_m); nuclear calcium concentration, ([Ca²⁺]_n); calcium influx factor, (CIF); 1)2-diacylglicerol, (DAG); endoplasmic reticulum, (ER); G protein-coupled receptors, (GPCR); inositol trisphosphate, (IP₃); nicotinic acid–adenine dinucleotide phosphate, (NAADP); phosphatidylinositol 4)5-bisphosphate, (PIP₂); protein kinase C, (PKC); Phospholipase C, (PLC); plasma membrane Ca²⁺ ATPase, (PMCA); receptor-operated channels, (ROC); sarcoendoplasmic reticulum Ca²⁺ ATPase, (SERCA); second messenger-operated channels, (SMOC); store-operated channels, (SOC); 2)5-di(tert-butyl)-1)4-benzohydroquinone, (TBHQ); transient receptor potential channelsf, (TRPC); voltage-operated Ca²⁺ channels, (VOC)

Received: 20 July 2004; Accepted: 02 August 2004; electronically published: August 2004

Summary

Ca²⁺ is a ubiquitous and versatile intracellular messenger that regulates many different cellular processes such as contraction, secretion, fertilisation and proliferation. Cells increase the cytosolic Ca²⁺ concentration by releasing Ca²⁺ from internal stores or by opening Ca²⁺ channels in the plasma membrane to allow extracellular Ca²⁺ to enter. Several pumps and exchangers are responsible for returning the elevated levels of cytosolic Ca²⁺ back to the resting state when the stimulus is terminated. The mitochondrion also plays an important role in that it is involved in the removal process by taking Ca²⁺ up from the cytosol, which might then be slowly released. The Ca²⁺ signalling systems are constantly being remodelled in both health and disease, and a disorder in Ca²⁺ homeostasis has been reported in tumoral cells. This review summarises the mechanisms that regulate intracellular Ca²⁺ homeostasis and the alterations in the Ca²⁺ transport systems that are involved in the development of tumorigenesis.

I. Introduction

Calcium is a chemical element widely distributed in nature, whose physiological relevance was demonstrated by Ringer in 1883. The presence of calcium in the extracellular medium was necessary for muscle contraction. One century later it was shown that in response to a signal ionised calcium (Ca²⁺) is released to the cytoplasm from an intracellular calcium store (Streb et al, 1983). In resting conditions, eukaryotic cells are surrounded by an extracellular medium containing a concentration of Ca²⁺ ([Ca²⁺]_o) of 1.2 mM and the Ca²⁺ concentration into the main intracellular stores ([Ca²⁺]_s) ranges from 0.1 to 1 mM. By contrast, the Ca²⁺ concentrations in the cytoplasm ([Ca²⁺]_c), mitochondria ([Ca²⁺]_m) and nucleus ([Ca²⁺]_n) are about 100 nM (Petersen, 2002; Berridge et al, 2003).

When an agonist binds to a specific receptor site on the outside of a cell membrane, a transduction process occurs, creating an intracellular signal. In many cases, the signal is a rise in [Ca²⁺]_c. The increase in [Ca²⁺]_c is induced by the release of compartmentalised Ca²⁺ from intracellular stores and/or the entry of extracellular Ca²⁺ across the plasma membrane. Immediately after agonist stimulation several mechanisms, mainly pumps and exchangers, remove Ca²⁺ from the cytosol, pumping this ion outside the cell or into intracellular stores, to restore the resting [Ca²⁺]_c (Petersen, 2002; Berridge et al, 2003; Schulz and Krause, 2004).

The physiological implications of Ca²⁺ range from the role in muscle (Mc Carron et al, 2004; Morales et al, 2004) or secretory tissues (Salido et al, 1999; Raraty et al, 2000) to neural transmission (Yamashita and Sugioka, 1998; Braet et al, 2004). Additionally, Ca²⁺ is an intracellular messenger for cellular growth and proliferation (Short et al, 1993).

Accumulating evidence suggests that altered cytosolic Ca²⁺ homeostasis might be involved with excessive cell proliferation, a hallmark of tumorigenesis.

II. Mechanisms of Ca²⁺ signalling

A. Calcium release from intracellular stores

Ca²⁺ release from the intracellular compartments is regulated by channels located in the membrane of the stores, such as the IP₃ receptor, the ryanodine receptor, the NAADP receptor and the sphingosine 1-phosphate receptor (Figure 1; Berridge et al, 2000).

1. The inositol trisphosphate (IP₃) receptor

The molecule that regulate the opening of this channel is inositol 1,4,5 trisphosphate (IP₃), generated by the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP₂) by phospholipase C_b (PLC_b) after the occupation of G-protein coupled receptors or by growth factor receptors coupled to PLC_(Bernstein et al, 1992; Kim et al, 2000)

At least three IP₃ receptor isoforms have been described, that appear as homo- and heterotetramers (Monkawa et al, 1995; Vermassen et al, 2004). Structurally, IP₃ receptors have three different domains: a N-terminus cytoplasmic domain with an IP₃ binding site, a regulatory central domain, which binds allosteric effectors such as Ca²⁺ or ATP (Mikoshiba, 1993; Sato et al, 2004), and a transmembrane region near the C terminus composed of six-spanning domains, involved in the formation of a tetrameric complex (Sayers et al, 1997;

Figure 1. Mechanisms of calcium signalling. Cell stimulation by agonists activate the formation of second messengers that induce the release of Ca²⁺ stored in the endoplasmic/sarcoplasmic reticulum (ER/SR) through the IP₃ receptor (IP₃R), the ryanodine receptor (RyR), the NAADP receptor (NAADPR) or the sphingosine 1-phosphate binding site (S1P-R). In addition, agonists stimulate the entry of extracellular Ca²⁺ through plasma membrane channels. Most of the cytosolic Ca²⁺ is bound to buffers, and only a small percentage binds to effectors and activates cellular functions. Ca²⁺ removal is mediated by various pumps and exchangers, including the Na⁺/Ca²⁺ exchanger (NCX) and the plasma membrane Ca²⁺ ATPase (PMCA) that extrude Ca²⁺ from the cytosol and the sarcoendoplasmic reticulum Ca²⁺-ATPase (SERCA) that pumps Ca²⁺ back to the ER/SR. During the Ca²⁺ signal mitochondria sequester Ca²⁺ through an uniporter that might be then released slowly into the cytoplasm through the NCX or the permeability transition pore (PTP).

Hamada et al, 2003). Cytosolic Ca²⁺ exerts a dual effect on the activity of the IP₃ receptor, so that low Ca²⁺ concentrations (<300 nM) are stimulatory while higher concentrations are either inhibitory or, after IP₃ binding, do not alter IP₃ receptor activity (Bootman and Lipp, 1999; Berridge et al, 2000).

2. The ryanodine receptor

Ryanodine receptors were described in the skeletal muscle as a tetrameric channel responsible for sarcoplasmic reticulum Ca²⁺ release (Pessah et al, 1985). As for the IP₃ receptors, there are also three ryanodine receptor isoforms. These channels are regulated by several chemical signals, such as cyclic ADP ribose, Ca²⁺ itself, caffeine, or the neutral plant alkaloid ryanodine (McPherson and Campbell, 1993). In skeletal muscle, ryanodine receptors are activated by direct coupling to L-type Ca²⁺ channels facilitated by the proximity of the T tubules and the sarcoplasmic reticulum (McPherson and Campbell, 1993).

3. NAADP receptor

The discovery of Ca²⁺ release by NAADP in sea urchin eggs (Lee and Aarhus, 1995) described a new mechanism for Ca²⁺ mobilisation. NAADP receptors are likely located on Ca²⁺ stores distinct from the endoplasmic reticulum, which have been identified as acidic organelles (Yamasaki et al, 2004). The activation of these channel evokes complex changes in [Ca²⁺]_c, which involve cross-talk with the IP₃ and ryanodine receptors (Patel, 2004). NAADP initiates the activation of Ca²⁺-induced Ca²⁺ release from IP₃- and cyclic ADP ribose-sensitive stores, leading to an oscillatory pattern (Santella et al, 2000; Churchill and Galione, 2001). A complex cross-talk between NAADP, IP₃ and ryanodine receptors has been described in pancreatic acinar cells, where acetylcholine-stimulated local Ca²⁺ responses, which are triggered via IP₃ receptors, are converted into global responses by the presence of NAADP or cyclic ADP ribose, and Ca²⁺ mobilisation stimulated by cholecystokinin, mediated by converging pathway, involving cyclic ADP ribose and NAADP, is potentiated by IP₃ (Cancela et al, 1999).

4. Sphingosine 1-phosphate receptor

Sphingosine 1-phosphate is a second messenger that releases Ca²⁺ from the endoplasmic reticulum by possibly binding to a sphingolipid Ca²⁺-release-mediating protein on the membrane of the endoplasmic reticulum (Mao et al, 1996). Alternatively, this lipid might activate ryanodine receptors, since sphingosine 1-phosphate enhances ryanodine binding to its receptor and Ca²⁺ release by sphingosine 1-phosphate is prevented by ryanodine receptor blockers (Dettbarn et al, 1995).

B. Calcium entry

In excitable cells, such as neurones and muscle cells, Ca²⁺ entry mostly occurs through voltage-operated Ca²⁺ channels (VOC); however, in non-excitable cells, where VOC are not present Ca²⁺ influx mainly occurs through receptor-operated channels (ROC), second messenger-operated channels (SMOC) or store-operated channels (SOC).

VOCs are Ca²⁺ permeable channels that are briefly activated by changes in the membrane potential (Tsien et al, 1995). These channels are mainly found in excitable cells, where they open in response to membrane depolarisations to allow Ca²⁺ to enter the cell (McCleskey, 1994).

ROC belong to a heterogeneous family of channels that are specially relevant in secretory cells and neurones. ROCs are activated by a number of cellular agonists inducing a rapid Ca²⁺ entry indicative of a direct coupling between the receptor and a Ca²⁺ permeable channel (Sage, 1992).

SMOC are Ca²⁺ channels activated by a second messenger, such as inositol phosphate or Ca²⁺ itself (Sage, 1992). These channels have been described mainly in non excitable cells. In endothelial cells, a Ca²⁺ channel activated by Ca²⁺ and inositol 1,3,4,5-tetrakisphosphate has been found (Lückhoff and Clapham, 1992). In human platelets, thrombin activates a store-independent (non-capacitative) Ca²⁺ entry, which is mediated by PKC (Rosado and Sage, 2000a). In addition, some transient receptor potential channels (TRPC) have been reported to be activated by DAG analogues in different non-excitable cells (Ma et al, 2000).

The major mechanism for Ca²⁺ entry in non-excitable cells is store-operated Ca²⁺ entry through SOC, controlled by the filling state of the intracellular Ca²⁺ stores. It is not yet clear how store depletion is communicated to the plasma membrane but a number of hypotheses have been suggested that can be divided into those which propose a role for a diffusible messenger and those which propose a direct interaction between proteins in the ER and PM (conformational coupling). Diffusible messengers include cyclic GMP, small GTP-binding proteins, a product of cytochrome P450, tyrosine kinases and a yet unknown Ca²⁺ influx factor (CIF; Parekh and Penner, 1997). Alternatively the conformational coupling model suggests an interaction between the IP₃ receptor (IP₃R) in the membrane of the ER and a Ca²⁺ channel in the PM (Berridge, 1995).

The conformational coupling has recently received support from studies that propose a secretion-like coupling for the activation of SMCE (Patterson et al, 1999; Rosado et al, 2000a; Redondo et al, 2003). The secretion-like coupling appears as an integrative model where messenger molecules and the actin cytoskeleton interact to facilitate a physical and reversible coupling between elements in the ER and PM. Consistent with this proteins of the Ras family and tyrosine kinases, initially considered as members of the diffusible messenger hypothesis for the activation of SMCE, are essential for actin reorganisation induced by store depletion (Rosado and Sage, 2000b; Rosado et al, 2000b) and proteins classically involved in exocytosis, such as SNAP-25 appear to be involved in Ca²⁺ entry (Yao et al, 1999; Redondo et al, 2004) . In addition, remodelling of the cytoskeletal cortical barrier has been suggested to facilitate the activation of SMCE by CIF (Xie et al, 2002).

The secretion-like coupling model for the activation of SMCE proposes a direct interaction between the IP₃Rs in the ER and a Ca²⁺ channel in the PM. The involvement of IP₃Rs in SMCE has widely been confirmed (Irvine, 1990; Mikoshiba, 1997), and the role of mammalian homologues of the Drosophila TRPC has received support from studies that demonstrate coupling between TRPCs and IP₃Rs in transfected cells (Kiselyov et al, 1998; Vazquez et al, 2001) and in cells naturally expressing TRPCs (Rosado and Sage, 2000c; Rosado et al, 2002). In this model, the actin cytoskeleton plays a dual role as for secretion, both as a cortical barrier preventing constitutive coupling and also supporting the transport of portions of the ER towards the PM (Rosado and Sage, 2001).

C. Mechanisms for calcium removal from the cytosol

Ca²⁺ removal from the cytosol is carried out by several Ca²⁺ pumps and exchangers which reintroduce Ca²⁺ into the internal stores or extrude it out of the cell (Meldolesi and Pozzan, 1998).

1. Calcium reuptake into internal stores

Ca²⁺ uptake into the intracellular stores mostly occurs against a concentration gradient, since [Ca²⁺]_c is lower than [Ca²⁺]_s which at rest is in a high-micromolar to low-millimolar concentration range. Released Ca²⁺ is returned to the stores by the sarcoendoplasmic reticulum Ca²⁺ ATPase (Figure 1; SERCA). There are three different SERCA genes, and additional isoform subtypes are generated by alternative splicing (Exton, 1997). SERCA has a high affinity for Ca²⁺ (0.1-0.4 mM), which suggests that SERCA is likely to be activated by an increase in [Ca²⁺]_c and inhibited by an increase in [Ca²⁺]_s (Carafoli, 1992).

Several pharmacological tools, such as thapsigargin, 2,5-di(tert-butyl)-1,4-benzohydroquinone (TBHQ) and cyclopiazonic acid, have been developed to investigate the role of SERCA in Ca²⁺ signalling. Among them, the most widely used is thapsigargin, which binds to all SERCAs although with different affinity (Cavallini et al, 1995) and causes an irreversible inhibition of their activity by blocking the ATPase in the Ca²⁺-free state (Wictome et al, 1992). A similar effect is induced with TBHQ, although with lower potency, and some isoforms seems to be insensitive to this inhibitor, which has been used to identify distinct intracellular Ca²⁺ stores (Cavallini et al, 1995) that, in turn, activate different Ca²⁺ entry mechanisms (Rosado et al, 2004).

2. Calcium extrusion across the plasma membrane

Perhaps the major mechanism for the removal of cytosolic Ca²⁺ is the extrusion of Ca²⁺ to the extracellular medium against a concentration gradient. Ca²⁺ efflux is mainly carried out by two different transporters, the plasma membrane Ca²⁺ ATPase (PMCA) and the Na⁺/Ca²⁺ exchanger (Figure 1).

The PMCA is an ATPase highly sensitive to vanadate and lanthanum (Pedersen and Carafolli, 1987; Pariente et al, 1999; Lajas et al, 2001). Molecular biology studies revealed the expression of at least four PMCA isoforms in humans: PMCA1-4, although its number is increased by the existence of alternative splice variants (Strehler and Zacharias, 2001). The structure of the PMCA consists of ten transmembrane domains and five extracellular regions, with the NH2 and COOH termini located in the cytosolic site of the membrane (Guerini, 1998; Strehler and Zacharias, 2001).

PMCA activity is regulated by several messenger molecules including Ca²⁺/calmodulin, protein tyrosine kinases, PIP₂, protein serine/threonine kinases and by proteases like calpain (Strehler and Zacharias, 2001; Pariente et al, 2003) and agonists might either increase or inhibit the PMCA activity by activating these intracellular pathways (Rosado and Sage, 2000d; Pariente et al, 2001).

On the other hand, the Na⁺/Ca²⁺ exchanger is a bi-directional electrogenic ion transporter that couples the movement of Na⁺ in one direction with the transport of Ca²⁺ in the opposite direction. The Na⁺/Ca²⁺ exchanger modulates [Ca²⁺]_c by either removing Ca²⁺ from the cytosol (forward mode) or by transporting Ca²⁺ inside the cell (reverse mode). Three different Na⁺/Ca²⁺ exchangers have been described. Two of them are electrogenic, the K⁺-independent Na⁺/Ca²⁺ exchanger, which catalyses the countertransport of either 3 or 4 Na⁺ for 1 Ca²⁺ (Blaustein and Lederer, 1999) and the K⁺-dependent Na⁺/Ca²⁺ exchanger, which catalyses the exchange of 4 Na⁺ by 1 Ca²⁺ and 1 K⁺ (Dong et al, 2001). In addition, an electroneutral Na⁺/Ca²⁺ exchanger has been described in mitochondria (Matsuda et al, 1997).

3. Role of mitochondria in Ca²⁺ signalling

Mitochondria are a relevant component of the Ca²⁺ signalling machinery. Localised in the vicinity of the Ca²⁺ channels, mitochondria sequesters Ca²⁺ coming from intracellular stores or the extracellular medium modulating the Ca²⁺ signals (Figure 1; Gonzalez and Salido, 2001; Parekh, 2003).

Ca²⁺ entry into mitochondria is regulated by a high capacity and low affinity uniporter that transports Ca²⁺ down a electrochemical gradient. This uniporter requires local high [Ca²⁺]_c to function suggesting that mitochondria should be close to the Ca²⁺ channels (Berridge et al, 2000; Pariente et al, 2003). Efflux of Ca²⁺ occurs by two different exchangers that countertransport Ca²⁺ for either Na⁺ or H⁺, or through a permeability transition pore that have two different states, a reversible low conductance state, that allow mitochondria to participate in Ca²⁺ signalling and an irreversible high conductance state that collapses the mitochondrial membrane potential leading to the activation of apoptosis (Ichas et al, 1997; Berridge et al, 2000).

Mitochondrial Ca²⁺ accumulation has a dual role in cell function, an universal role that consist in the activation of mitochondrial enzymes involved in the generation of ATP, and a more specific role involved in the modulation of the spatio-temporal aspects of Ca²⁺ signalling (Camello-Almaraz et al, 2002; Brini, 2003; Gonzalez et al, 2003; Parekh, 2003).

4. Ca²⁺ binding proteins

It is well known that approximately 98-99 % of Ca²⁺ ions in the cytosol are bound by buffer molecules, including Ca²⁺ binding proteins (Neher and Augustine, 1992; Mogami et al, 1999). There is a variety of Ca²⁺-binding proteins involved in Ca²⁺ signalling either acting as Ca²⁺ sensors, effectors or buffers that either initiate, execute or terminate Ca²⁺-dependent functions. Most of Ca²⁺-binding molecules inside the cell are Ca²⁺ buffer proteins that maintain a low [Ca²⁺]_c at rest, including calretinin, calbindin and parvalbumin in the cytosol and calsequestrin and calreticulin in the intracellular stores.

III. Ca²⁺ signalling in cancer

Cancer is a disease characterised by a complete deregulation of the cell proliferation cycle. It is well known that cell exposure to external agents, such as some heavy metals (Krantz and Dorevicht, 2004), virus infection (Shah et al, 2004) or radiations, increases the number of cancer incident. In addition, intracellular signals can also induce tumorigenesis. Among the different cancer types and locations, lung, skin or prostate cancer in men and breast cancer in women appear as the more common neoplasia.

To understand the mechanism involved in gene deregulation, we have to investigate the signalling mechanisms that induce the activation of transcription factors (Arbiser, 2004), where Ca²⁺ signals are among the most important pathways involved in tumorigenesis (Lipskaia and Lompré, 2004). A number of studies have reported alterations in Ca²⁺ homeostasis in tumoral cells, ranging from those that affect the [Ca²⁺]_o to those that involve dysfunction of one or several intracellular Ca²⁺ mobilising mechanism.

Since cancer is predominantly a disease of disordered balance between proliferation, differentiation and apoptosis, an altered function of the extracellular calcium-sensing receptors (CaR) might contribute to the progression of the neoplastic disease. Parathyroid hyperplasias as well as colon carcinoma have been shown to be correlated with an altered expression of CaR (Mart£n-Salvago et al, 2003; Rodland, 2004), leading to loss of the growth suppressing effects of elevated extracellular Ca²⁺. CaR dysfunction has been reported to be involved in cancer progression and its activation has been linked to an increased expression and secretion of parathyroid hormone-related peptide, a promoter of the metastatic progress in bone as well as a causal factor involved in hypercalcemia of malignancy (Rodland, 2004).

The mechanisms involved in the regulation of [Ca²⁺]_c are also either involved or altered in tumoral cells. In the last years a number of studies have provided information about the transduction mechanisms involved in Ca²⁺ entry induced by mitogenic factors, binding either to tyrosine kinase receptors or to G protein coupled receptors. Among the early events induced by mitogens Ca²⁺ mobilisation and specially Ca²⁺ entry are widespread signals (Munaron, 2002), which supports the involvement of Ca²⁺ signalling in the development of neoplastic transformation.

In preneoplastic mouse JB6 epidermal cells extracellular Ca²⁺ entry has been shown to be necessary for the induction of neoplastic transformation and cell treatment with calcium channel blockers, such as lanthanum or nifedipine, reduce their transformation (Smith et al, 1986). In addition, the sustained Ca²⁺ store depletion and prevention of the refilling via SMCE influences the rate of cellular protein synthesis and reduces cell proliferation in experimental cancer (Palakurthi et al, 2000). These results indicate that cell transformation requires the influx of external Ca²⁺ and in most cases it has been shown to accelerate Ca²⁺ entry; therefore, reduction of this mechanism might reduce the progression of the tumour and might be one of the targets of cancer therapy. This is the case of the human prostate cancer cells, where blockade of the Ca²⁺ entry by using TH-1177, extend the mean life span in mice inoculated with these cells by 38 % without obvious cytotoxicity (Haverstic et al, 2000). In addition, a potential antitumor action for another Ca²⁺ channel blocker, the dihydropyridine amlodipine, has recently been described (Yoshida et al, 2004). Amlodipine has been reported to reduce the tumour growth and increase the survival of mice inoculated with human epidermoid carcinoma A431 cells (Yoshida et al, 2004).

Several alterations have also been observed in the function of the mechanisms involved in Ca²⁺ removal from the cytosol, which indicate that this transporters might be involved in the development of neoplasia. Recent studies have reported that an altered expression of the PMCA might occur in tumorigenesis. The expression of PMCA 1 in MCF-7 and MDA-MB-231 breast cancer cells is significantly increased compared to that in normal cells (Lee et al, 2002). This effect might be a cause of the cell transformation or a response to this stimuli since PMCA expression has been shown to be lower in skin and lung fibroblast transformed by treatment with SV40 (Reisner et al, 1997).

An interesting issue that is still unclear is how cancer cells avoid apoptosis. It has been reported that early preneoplastic cells are highly susceptible to apoptosis, whereas later preneoplastic cells are quite resistant (Preston et al, 1997). Although several hypothesis have been proposed to explain the resistance to apoptosis, a plausible mechanism involving Ca²⁺ signalling has been presented, in which reduced Ca²⁺ levels in the ER were observed in early preneoplastic cells that undergo apoptosis compared to a higher level of stored Ca²⁺ in the ER in late preneoplastic cells. The mechanism by which these cells accumulated different amount of Ca²⁺ in the ER lies on the different activation of SMCE. In late preneoplastic cells, less susceptible to apoptosis and therefore with a great potential to become transformed, Ca²⁺ entry is increased compared to that found in cells in the early steps of neoplastic transformation (Preston et al, 1997). The role of Ca²⁺ entry in apoptosis is supported by a more recent report suggesting that a reduced SMCE correlates with the development of apoptosis (Jayadev et al, 1999).

In the last decade, the scientists have considerably advanced in the cancer therapy, trying to apply genetic therapy to stop the development of several cancer types. At present, there is not treatment that can totally sure the cancer elimination, and quite often they found another problem, cancer cells can leave the main focus, travel around the body and proliferate in other substrate, the so called metastatic cells. The current therapies usually have severe side effects in the patients. However, the recent observations provide reasons to be optimistic and raise the possibility that directed synthesis of novel and specific Ca²⁺ channel blockers or inhibitors of Ca²⁺ mobilising mechanisms could be useful in the therapy of cancer by minimising effects on normal organs and cells and by maximising the cytostatic efficacy for the neoplastic tissue of clinical concern.

References

Arbiser JL (2004) Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms. Semin Cancer Biol 14, 81-91.

Berridge MJ (1995) Capacitative calcium entry. Biochem J 312, 1-11.

Berridge MJ, Bootman MD and Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev 4, 517-529.

Berridge MJ, Lipp P and Bootman MD (2000) The versatility and universatility of calcium signalling. Nat Rev 1, 11-21.

Berstein G, Blank JL, Smrcka AV, Higashijima T, Sternweis PC, Exton JH and Ross E M. (1992) Reconstitution of agonist-stimulated phosphatidylinositol 4,5-bisphosphate hydrolysis using purified m1 muscarinic receptor, Gq/11 and phospholipase C-b 1. J Biol Chem 267, 8081-8088.

Blaustein MP and Lederer WJ (1999) Sodium/Calcium Exchange: Its Physiological Implications. Physiol Rev 79, 763-854.

Bootman MD and Lipp P (1999) Calcium signalling: Ringing changes to the “bell-shaped curve”. Curr Biol 9, 876-878.

Braet K, Cabooter L, Paemeleire K and Leybaert L (2004) Calcium signal communication in the central nervous system. Biol Cell 96, 79-91.

Brini M (2003) Ca²⁺ signalling in mitochondria: mechanism and role in physiology and pathology. Cell Calcium 34, 399-405.

Camello-Almaraz C, Salido GM, Pariente JA and Camello PJ (2002) Role of mitochondria in Ca²⁺ oscillation and shape of Ca²⁺ signals in pancreatic acinar cells. Biochem Pharmacol 63, 283-292.

Cancela JM, Churchill GC and Galione A (1999) Coordination of agonist-induced Ca²⁺-signalling patterns by NAADP in pancreatic acinar cells. Nature 398, 74-76.

Carafoli E (1992) Calcium pump of the plasma membrane. Physiol Rev 71, 283-292.

Cavallini L, Coassin M and Alexandre A (1995) Two classes of agonist-sensitive Ca²⁺ stores in platelets, as identified by their differential sensitivity to 2,5-di-(tert-butyl)-1,4-benzohydroquinone and thapsigargin. Biochem J 310, 449-452.

Churchill GC and Galione A (2001) NAADP induces Ca²⁺ oscillations via a two-pool mechanism by priming IP₃- and cADPR-sensitive Ca²⁺ stores. EMBO J 20, 2666-2671.

Dettbarn C, Betto R, Salviati G, Sabbadini R and Palade P (1995) Involvement of ryanodine receptors in sphingosylphosphorylcholine-induced calcium release from brain microsomes. Brain Res 669, 79–85.

Dong, H, Light PE, French RJ and Lytton J (2001) Electrophysiological characterization and ionic stoichiometry of the rat brain K+-dependent Na⁺-Ca²⁺ exchanger, NCKX2. J Biol Chem 276, 25919-25928.

Exton JH (1997) New developments in phospholipase D. J Biol Chem 272, 15579-15582.

Gonzalez A, Granados MP, Salido GM and Pariente JA. (2003) Changes in mitochondrial activity evoked by cholecystokinin in isolated mouse pancreatic acinar cells. Cell Signal 15, 1039-1048.

Gonzalez A, Salido GM (2001) Participation of mitochondria in calcium signalling in the exocrine pancreas. J Physiol Biochem 57, 331-339.

Guerini D (1998) The significance of the isoforms of plasma membrane calcium ATPase. Cell Tissue Res 292, 191-197.

Hamada K, Terauchi A and Mikoshiba K (2003) Three-dimensional rearrangements within inositol 1,4,5-trisphosphate receptor by calcium. J Biol Chem 278, 52881-52889.

Haverstick DM, Heady TN, Macdonald TL and Gray LS. (2000) Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca²⁺ entry. Cancer Res 60, 1002-1008.

Ichas F, Jouaville LS and Mazat JP (1997) Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell 89, 1145-1153.

Irvine RF (1990) 'Quantal' Ca²⁺ release and the control of Ca²⁺ entry by inositol phosphates--a possible mechanism. FEBS Lett 263, 5-9.

Jayadev S, Petranka JG, Cheran SK, Biermann JA, Barrett JC and Murphy E (1999) Reduced capacitative calcium entry correlates with vesicle accumulation and apoptosis. J Biol Chem 274, 8261-8268.

Kim MJ, Kim E, Ryu SH and Suh PG (2000) The mechanism of phospholipase C-gamma1 regulation. Exp Mol Med 32, 101-109.

Kiseljov K, Xu X, Mozhayeva G, Kuo T, Pessah I, Mignery G, Zhu X, Birnbaumer L and Muallem S (1998) Functional interaction between InsP₃ receptors and store-operated Htrp3 channels. Nature 396, 478-482.

Krantz A, Dorevitch S (2004) Metal exposure and common chronic diseases: a guide for the clinician. Dis Mon 50, 220-262.

Lajas AI, Sierra V, Camello PJ, Salido GM and Pariente JA (2001) Vanadate inhibits the calcium extrusion in rat pancreatic acinar cells. Cell Signal 13, 451-456.

Lee HC and Aarhus R (1995) A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose. J Biol Chem 270, 2152-2157.

Lee WJ, Roberts-Thomson SJ, Holman NA, May FJ, Lehrbach GM and Monteith GR (2002) Expression of plasma membrane calcium pump isoform mRNAs in breast cancer cell lines. Cell Signal 14, 1015-1022.

Lipskaia L and Lompre AM. (2004) Alteration in temporal kinetics of Ca²⁺ signaling and control of growth and proliferation. Biol Cell 96, 55-68.

Lückhoff A and Clapham DE (1992) Inositol 1,3,4,5-tetrakisphosphate activities an endothelial Ca²⁺-permeable channel. Nature 335, 356-358.

Ma HT, Patterson RL, van Rossum DB, Birnbaumer L, Mikoshiba K and Gill DL (2000) Requirement of the inositol trisphosphate receptor for activation of store-operated Ca²⁺ channels. Science 287, 1647-1651.

Mao C, Kim SH, Almenoff JS, Rudner XL, Kearney DM and Kindman LA (1996) Molecular cloning and characterization of SCaMPER, a sphingolipid Ca²⁺ release-mediating protein from endoplasmic reticulum. Proc Natl Acad Sci USA 93, 1993–1996.

Martin-Salvago M, Villar-Rodriguez JL, Palma-Alvarez A, Beato-Moreno A and Galera-Davidson H. (2003) Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure. Endocr Pathol 14, 61-70.

Matsuda T, Takuma K and Baba A (1997) Na⁺-Ca²⁺ exchanger: physiology and pharmacology. Jpn J Pharmacol 74, 1-20.

McCarron JG, Bradley KN, MacMillan D, Chalmers S and Muir TC. (2004) The sarcoplasmic reticulum, Ca2+ trapping and wave mechanisms in smooth muscle.
News Physiol Sci 19, 138-147.

McCleskey EW (1994) Calcium channels: cellular roles and molecular mechanisms. Curr Opinion Neurobiol 4, 304-312.

McPherson PS and Campbell KP (1993) The ryanodine receptor/Ca²⁺ release channel. J Biol Chem 268, 13765-13768.

Meldolesi J and Pozzan T (1998) The endoplasmic reticulum Ca²⁺ store: a view from the lumen. Trends Biochem Sci 23, 10-14.

Mikoshiba K (1993) Inositol 1,4,5-trisphosphate receptor. Trends Pharmacol Sci 14, 86-89.

Mikoshiba K (1997) The InsP₃ receptor and intracellular Ca²⁺ signaling. Curr Opin Neurobiol 7, 339-345.

Mogami H, Gardner J, Gerasimenko OV, Camello P, Petersen OH and Tepikin AV (1999) Calcium binding capacity of the cytosol and endoplasmic reticulum of mouse pancreatic acinar cells. J Physiol 518, 463-467.

Monkawa T, Miyawaki A, Sugiyama T, Yoneshima H, Yamamoto-Hino M, Furuichi T, Saruta T, Hasegawa M and Mikoshiba K (1995) Heterotetrameric complex formation of inositol 1,4,5-trisphosphate receptor subunits. J Biol Chem 270, 14700-14704.

Morales S, Camello PJ, Alcon S, Salido GM, Mawe G and Pozo MJ (2004) Coactivation of capacitative calcium entry and L-type calcium channels in guinea pig gallbladder. Am J Physiol Gastrointest Liver Physiol 286, 1090-1100.

Munaron L (2002) Calcium signalling and control of cell proliferation by tyrosine kinase receptors. Int J Mol Med 10, 671-676.

Neher E and Augustine GJ (1992) calcium gradients and buffers in bovine chromaffin cells. J Physiol 450, 273-301.

Palakurthi SS, Fluckiger R, Aktas H, Changolkar AK, Shahsafaei A, Harneit S, Kilic E and Halperin JA. (2000) Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res 60, 2919-2925.

Parekh AB (2003) Mitochondrial regulation of intracellular Ca²⁺ signaling: more than just simple Ca²⁺ buffers. News Physiol Sci 18, 252-256.

Parekh AB and Penner R (1997) Store depletion and calcium influx. Physiol Rev 77, 901-930.

Pariente JA, Camello C, Camello PJ and Salido GM (2001) Release of calcium from mitochondrial and nonmitochondrial intracellular stores in mouse pancreatic acinar cells by hydrogen peroxide. J Membr Biol 179, 27-35.

Pariente JA, Lajas AI, Pozo MJ, Camello PJ and Salido GM (1999) Oxidizing effects of vanadate on calcium mobilization and amylase release in rat pancreatic acinar cells. Biochem Pharmacol 58, 77-84.

Pariente JA, Redondo PC, Granados MP, Lajas AI, Gonzalez A, Rosado JA and Salido GM (2003) Calcium signaling in non-excitable cells. E. C. Qua. L. 1, 29-43.

Patel S (2004) NAADP-induced Ca²⁺ Release - a new signalling pathway. Biol Cell 96, 19-28.

Patterson RL, van Rossum DB and Gill DL (1999) Store-operated Ca²⁺ entry: evidence for a secretion-like coupling model. Cell 98, 487-499.

Pedersen PL and Carafoli E (1987) Ion motive ATPase. I. Ubiquity, properties and significance for cell function. Trends Biochem Sci 12, 146-150.

Pessah IN, Waterhouse AL and Casida JE (1985) The calcium-ryanodine receptor complex of skeletal and cardiac muscle. Biochem Biophys Res Commun 128, 449-456.

Petersen OH (2002) Calcium signal compartmentalization. Biol Res 35, 177-182.

Preston GA, Barrett JC, Biermann JA and Murphy E (1997) Effects of alterations in calcium homeostasis on apoptosis during neoplastic progression. Cancer Res 57, 537-542.

Raraty M, Ward J, Erdemli G, Vaillant C, Neoptolemos JP, Sutton R, Petersen OH. (2000) Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells. Proc Natl Acad Sci USA 97, 13126-13131.

Redondo PC, Harper AG, Salido GM, Pariente JA, Sage SO and Rosado JA (2004) A role for SNAP-25 but not VAMPs in store-mediated Ca²⁺ entry in human platelets. J Physiol 558, 99-109.

Redondo PC, Lajas AI, Salido GM, Gonzalez A, Rosado JA and Pariente JA (2003) Evidence for secretion-like coupling involving pp60^src in the activation and maintenance of store-mediated Ca²⁺ entry in mouse pancreatic acinar cells. Biochem J 370, 255-263.

Reisner PD, Brandt PC and Vanaman TC. (1997) Analysis of plasma membrane Ca²⁺-ATPase expression in control and SV40-transformed human fibroblasts. Cell Calcium 21, 53-62.

Ringer S (1883) A further contribution regarding the influence of the different constituents of the blood and the contraction of the heart. J Physiol 4, 29-43.

Rodland KD (2004) The role of the calcium-sensing receptor in cancer. Cell Calcium 35, 291-295.

Rosado JA and Sage SO (2000a) Protein kinase C activates non-capacitative calcium entry in human platelets. J Physiol 529, 159-169.

Rosado JA and Sage SO (2000b) Farnesylcysteine analogues inhibit store-regulated Ca²⁺ entry in human platelets: evidence for involvement of small GTP-binding proteins and actin cytoskeleton. Biochem J 347, 183-192.

Rosado JA and Sage SO (2000c) Coupling between inositol 1,4,5-trisphosphate receptors and human transient receptor potential channel 1 when intracellular Ca²⁺ stores are depleted. Biochem J 350, 631-635.

Rosado JA and Sage SO (2000d) Regulation of plasma membrane Ca²⁺-ATPase by small GTPases and phosphoinositides in human platelets. J Biol Chem 275, 19529-19535.

Rosado JA and Sage SO (2001) Activation of store-mediated calcium entry by secretion-like coupling between the inositol 1,4,5-trisphosphate receptor type II and human transient receptor potential (hTrp1) channels in human platelets. Biochem J 356, 191-198.

Rosado JA, Brownlow SL and Sage SO (2002) Endogenously expressed Trp1 is involved in store-mediated Ca²⁺ entry by conformational coupling in human platelets. J Biol Chem 277, 42157-42163.

Rosado JA, Graves D and Sage SO (2000b) Tyrosine kinases activate store-mediated Ca²⁺ entry in human platelets through the reorganization of the actin cytoskeleton. Biochem J 351, 429-437.

Rosado JA, Jenner S and Sage SO (2000a) A role for the actin cytoskeleton in the initiation and maintenance of store-mediated calcium entry in human platelets. Evidence for conformational coupling. J Biol Chem 275, 7527-7533.

Rosado JA, Lopez JJ, Harper AG, Harper MT, Redondo PC, Pariente JA, Sage SO and Salido GM (2004) Two Pathways for Store-mediated Calcium Entry Differentially Dependent on the Actin Cytoskeleton in Human Platelets. J Biol Chem 279, 29231-29235.

Sage SO (1992) Three routes for receptor-mediated Ca²⁺ entry. Curr Biol 2, 312-314.

Salido GM, Singh J and Camello PJ (1999) Growth factors and the exocrine pancreas. Ars Pharmaceutica 40, 81-85.

Santella L, Kyozuka K, Genazzani AA, De Riso L and Carafoli E (2000) Nicotinic acid adenine dinucleotide phosphate-induced Ca²⁺ release. Interactions among distinct Ca²⁺ mobilizing mechanisms in starfish oocytes. J Biol Chem 275, 8301-8306.

Sato C, Hamada K, Ogura T, Miyazawa A, Iwasaki K, Hiroaki Y, Tani K, Terauchi A, Fujiyoshi Y and Mikoshiba K (2004) Inositol 1,4,5-trisphosphate receptor contains multiple cavities and L-shaped ligand-binding domains. J Mol Biol 336, 155-164.

Sayers LG, Miyawaki A, Muto A, Takeshita H, Yamamoto A, Michikawa T, Furuichi T and Mikoshiba K (1997) Intracellular targeting and homotetramer formation of a truncated inositol 1,4,5-trisphosphate receptor-green fluorescent protein chimera in Xenopus laevis oocytes: evidence for the involvement of the transmembrane spanning domain in endoplasmic reticulum targeting and homotetramer complex formation. Biochem J 323, 273-280.

Schulz I and Krause E (2004) Inositol 1,4,5-trisphosphate and its co-players in the concert of Ca²⁺ signalling-new faces in the line up. Curr Mol Medicine 4, 313-322.

Shah KV, Galloway DA, knowles WA and Viscidi RP (2004) Simian virus 40 (SV 40) and human cancer: a review of the serological data. Rev Med Virol 14, 231-239.

Short AD, Bian J, Ghosh TK, Waldron RT, Rybak SL and Gill DL (1993) Intracellular Ca²⁺ pool content is linked to control of cell growth. Proc Natl Acad Sci USA 90, 4986-4990.

Smith BM, Gindhart TD and Colburn NH (1986) Extracellular calcium requirement for promotion of transformation in JB6 cells. Cancer Res 1986 46, 701-706.

Streb H, Irvine RF, Berridge MJ and Schulz I (1983) Release of Ca²⁺ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 306, 67-69.

Strehler EE and Zacharias DA (2001) Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev 81, 21-50.

Tsien RW, Lipscombe D, Madison D, Bley K and Fox A (1995) Reflections on Ca²⁺-channel diversity, 1988-1994. Trends Neurosci 18, 52-54.

Vazquez G, Lievremont JP, Bird G and Putney JW Jr (2001) Human Trp3 forms both inositol trisphosphate receptor-dependent and receptor-independent store-operated cation channels in DT40 avian B lymphocytes. Proc Natl Acad Sci USA 98, 11777-11782.

Vermassen E, Parys JB and Mauger JP (2004) Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell 96, 3-17.

Wictome M, Henderson I, Lee AG and East JM (1992) Mechanism of inhibition of the calcium pump of sarcoplasmic reticulum by thapsigargin. Biochem J 283, 525-529.

Xie Q, Zhang Y, Zhai C and Bonanno JA (2002) Calcium influx factor from cytochrome P-450 metabolism and secretion-like coupling mechanisms for capacitative calcium entry in corneal endothelial cells. J Biol Chem 277, 16559-16566.

Yamasaki M, Masgrau R, Morgan AJ, Churchill GC, Patel S, Ashcroft SJ and Galione A (2004) Organelle selection determines agonist-specific Ca²⁺ signals in pancreatic acinar and b cells. J Biol Chem 279, 7234-7240.

Yamashita M, Sugioka M (1998) Calcium Mobilization Systems During Neurogenesis. News Physiol Sci 13, 75-79.

Yao Y, Ferrer-Montiel AV, Montal M and Tsien RY (1999) Activation of store-operated Ca²⁺ current in Xenopus oocytes requires SNAP-25 but not a diffusible messenger. Cell 98, 475-485.

Yoshida J, Ishibashi T and Nishio M. (2004) Antitumor effects of amlodipine, a Ca²⁺ channel blocker, on human epidermoid carcinoma A431 cells in vitro and in vivo. Eur J Pharmacol 492, 103-112.

Juan A. Rosado